206 related articles for article (PubMed ID: 11450667)
1. Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer.
Ledermann JA; Leonard P; Seymour M
N Engl J Med; 2001 Jul; 345(2):145-6. PubMed ID: 11450667
[No Abstract] [Full Text] [Related]
2. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
Erlichman C; Goldberg RM; O'Connell MJ
N Engl J Med; 2001 Jan; 344(4):305; author reply 306-7. PubMed ID: 11191661
[No Abstract] [Full Text] [Related]
3. Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer.
Sargent DJ; Niedzwiecki D; O'Connell MJ; Schilsky RL
N Engl J Med; 2001 Jul; 345(2):144-5; author reply 146. PubMed ID: 11450666
[No Abstract] [Full Text] [Related]
4. Recommendation for irinotecan, 5-fluorouracil, and leucovorin as first-line therapy for colorectal cancer.
Fisher MD
Clin Colorectal Cancer; 2001 Aug; 1(2):82-4. PubMed ID: 12445364
[No Abstract] [Full Text] [Related]
5. Moving beyond fluorouracil for colorectal cancer.
Mayer RJ
N Engl J Med; 2000 Sep; 343(13):963-4. PubMed ID: 11006373
[No Abstract] [Full Text] [Related]
6. Indications and effect on survival of standard chemotherapy in advanced colorectal cancer.
Kallinowski B
Recent Results Cancer Res; 2005; 165():245-9. PubMed ID: 15865040
[TBL] [Abstract][Full Text] [Related]
7. Irinotecan/5-FU/leucovorin, oxaliplatin/5-FU/leucovorin, and oxaliplatin/irinotecan are each effective in the treatment of 5-FU-resistant advanced colorectal cancer.
Fisher MD
Clin Colorectal Cancer; 2001 Aug; 1(2):85-6. PubMed ID: 12445365
[No Abstract] [Full Text] [Related]
8. Randomized trial comparing the addition of oxaliplatin or irinotecan to high-dose leucovorin and 5-Fluorouracil intravenous bolus every two weeks in metastatic colorectal carcinoma: Southern Italy Cooperative Oncology Group 0103.
Comella P
Clin Colorectal Cancer; 2003 Nov; 3(3):186-9. PubMed ID: 14706179
[No Abstract] [Full Text] [Related]
9. Evolution of systemic therapy for metastatic colorectal cancer.
Geh JI; Ma YT
Colorectal Dis; 2011 Aug; 13(8):852-4. PubMed ID: 21762349
[No Abstract] [Full Text] [Related]
10. Bevacizumab in colorectal cancer.
Sharieff W
N Engl J Med; 2004 Oct; 351(16):1690-1; author reply 1690-1. PubMed ID: 15490497
[No Abstract] [Full Text] [Related]
11. [Irinotecan plus fluorouracil and leucovorin for advanced colorectal cancer].
Motomura S
Nihon Rinsho; 2003 Sep; 61 Suppl 7():360-3. PubMed ID: 14574913
[No Abstract] [Full Text] [Related]
12. N9741: a phase III study comparing irinotecan to oxaliplatin-containing regimens in advanced colorectal cancer.
Goldberg RM
Clin Colorectal Cancer; 2002 Aug; 2(2):81. PubMed ID: 12453321
[No Abstract] [Full Text] [Related]
13. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
Vaiani M; Trippoli S; Messori A
N Engl J Med; 2001 Jan; 344(4):305-6; author reply 306-7. PubMed ID: 11191660
[No Abstract] [Full Text] [Related]
14. [Irinotecan plus fluorouracil and folinic acid in metastatic colorectal cancer].
Krieger G
Strahlenther Onkol; 2001 Jun; 177(6):316-8. PubMed ID: 11446323
[No Abstract] [Full Text] [Related]
15. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
Pignon JP; Ducreux M
N Engl J Med; 2001 Jan; 344(4):306; author reply 306-7. PubMed ID: 11191663
[No Abstract] [Full Text] [Related]
16. [Capecitabine and irinotecan].
Gasperoni S
Suppl Tumori; 2004; 3(4):S107-8. PubMed ID: 15206231
[No Abstract] [Full Text] [Related]
17. Adjuvant irinotecan regimens in combination with infusional 5-fluorouracil/leucovorin fail to improve outcomes in surgically resected colorectal cancer.
Tyagi P
Clin Colorectal Cancer; 2005 Jul; 5(2):86-8. PubMed ID: 16098248
[No Abstract] [Full Text] [Related]
18. Bimonthly leucovorin, infusion 5-fluorouracil, hydroxyurea, and irinotecan (FOLFIRI-2) for pretreated metastatic colorectal cancer.
Mabro M; Louvet C; André T; Carola E; Gilles-Amar V; Artru P; Krulik M; de Gramont A;
Am J Clin Oncol; 2003 Jun; 26(3):254-8. PubMed ID: 12796595
[TBL] [Abstract][Full Text] [Related]
19. Systemic chemotherapy for metastatic colorectal cancer: reasons to combine.
Calvo E
Clin Colorectal Cancer; 2002 Nov; 2(3):170-2. PubMed ID: 12482333
[No Abstract] [Full Text] [Related]
20. [Present status and prospect of irinotecan application in adjuvant therapy for colorectal cancer].
Zhou ZT; Wang JW
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):553-4. PubMed ID: 17147128
[No Abstract] [Full Text] [Related]
[Next] [New Search]
